Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of κ-opioid receptor agonists U-50,488H, but not TRK-820 in rats

Journal of Pharmacological Sciences

Volumn 100, Issue 2, 2006, Pages 157-161

  Mori, Tomohisa ^a,b   Nomura, Mutsuko ^a   Yoshizawa, Kazumi ^a   Nagase, Hiroshi ^c   Sawaguchi, Toshiko ^b   Narita, Minoru ^a   Suzuki, Tsutomu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

Drug discrimination; NMDA receptor antagonist; opioid receptor agonist

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; DIZOCILPINE; IFENPRODIL; KAPPA OPIATE RECEPTOR AGONIST; KETAMINE; NALFURAFINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG EFFECT; MALE; NONHUMAN; RAT; STIMULUS GENERALIZATION;

EID: 33244483012     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.SCJ05006X     Document Type: Article

References (20)

1. Schuster CR, Johanson CE. Relationship between the discriminative stimulus properties and subjective effects of drugs. In: Colpaert FC, Balster RL, editors. Psychopharmacology, Series 4: Transduction mechanisms of drug stimuli. Berlin: Springer-Verlag; 1988. p. 161-175.
2. Teal JJ, Holtzman SG. Discriminative stimulus effects of prototype opiate receptor agonists in monkeys. Eur J Pharmacol. 1980;68:1-10.
3. White JM, Holtzman SG. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioid with agonist and antagonist properties. J Pharmacol Exp Ther. 1983;224:95-99.
4. MacCarten MD, Lal H. Generalization study with some narcotic and nonnarcotic psychoactive drugs in rats trained to discriminate between cyclazocine and saline. In: Way E, editor. Endogenous and exogenous opiate agonists and antagonists. New York: Pergamon Press; 1980. p. 439-442.
5. Mori T, Nomura M, Yoshizawa K, Nagase H, Narita M, Suzuki T. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats. Life Sci. 2004;75: 2473-2482.
6. Kitaichi K, Noda Y, Miyamoto Y, Numaguchi A, Osawa H, Hasegawa T, et al. Involvement of the serotonergic neuronal system I phencyclidine-induced place aversion in rats. Behav Brain Res. 1999;103:105-111.
7. Nagase H, Hayakawa J, Kawamura K, Kawai K, Takezawa Y, Matsuura H, et al. Discovery of a structurally novel opioid κ-agonist derived from 4,5-epoxymorphinan. Chem Pharm Bull. 1998;46:366-369.
8. Hasebe K, Kawai K, Suzuki T, Kawamura K, Tanaka T, Narita M, et al. Possible pharmacotherapy of the opioid κ-receptor agonist for drug dependence. Ann NY Acad Sci. 2004;1025: 404-413.
9. Mori T, Nomura M, Nagase H, Narita M, Suzuki T. Effects of a newly synthesized κ-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Psychopharmacology. 2002;161:17-22.
10. Rimoy GH, Wright DM, Bhaskar NK, Rubin PC. The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist. Eur J Clin Pharmacol. 1994;46:203-207.
11. Walsh SL, Strain EC, Abreu ME, Bigelow GE. Enadoline, a selective κ opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology. 2001;157: 151-162.
12. Endoh T, Tajima A, Suzuki T, Kamei J, Narita M, Tseng L, et al. Characterization of the antinociceptive effects of TRK-820 in the rat. Eur J Pharmacol. 2000;387:133-140.
13. Suzuki T, Shiozaki Y, Masukawa Y, Misawa M, Nagase H. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn J Pharmacol. 1992;58:435-442.
14. Svensson TH. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Rev. 2000;31:320-329.
15. Holtzman SG, Cook L, Steinfels GF. Discriminative stimulus effects of spiradoline, a kappa-opioid agonist. Psychopharmacology. 1991;105:447-452.
16. Picker MJ, Doty P, Negus SS, Mattox SR, Dykstra LA. Discriminative stimulus properties of U50488 and morphine: effects of training dose on stimulus substitution patterns produced by mu and kappa opioid agonists. J Pharmacol Exp Ther. 1990;254:13-22.
17. Jackson A, Sanger DJ. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors? Psychopharmacology. 1988;96:87-92.
18. Willetts J, Balster RL. The discriminative stimulus effects of N-methyl-D-aspartate antagonists in phencyclidine-trained rats. Neuropharmacology. 1988;27:249-256.
19. Brady KT, Balster RL. Discriminative stimulus properties of ketamine stereoisomers in phencyclidine-trained rats. Pharmacol Biochem Behav. 1982;17:291-295.
20. Suzuki T, Kato H, Tsuda M, Suzuki H, Misawa M. Effects of the non-competitive NMDA receptor antagonist Ifenpridil on the morphine-induced place preference in mice. Life Sci. 1999;64:PL151-PL156.